At the 2nd International Glaucoma Symposium in Mainz, Germany, on 31 January 2026, optical coherence tomography (OCT) and its role in glaucoma and neuro-ophthalmic disease took centre stage in a ...

New research shows risankizumab delivers long-term psoriasis control, with OCT revealing reduced subclinical inflammation.

Over 52 weeks of treatment, risankizumab led to significant improvements in both clinical outcomes and optical coherence tomography (OCT) parameters, highlighting the value of long-term therapy ...

Risankizumab improved visible psoriasis and reduced subclinical vascular inflammation on optical coherence tomography over 52 ...

Spectral Domain OCT (SD-OCT) is projected to account for 59.4% of the global OCT market in 2025, supported by its high-resolution imaging and fast acquisition speeds, particularly in ophthalmology. SD ...

Optical coherence tomography (OCT), a tool routinely used to diagnose and plan treatment for eye diseases, has now been modified to collect images of the inner ear.

Endoscopic optical coherence tomography is widely used to visualize tissue microstructures in real time, but current probes ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...